Journal
NEUROLOGIA MEDICO-CHIRURGICA
Volume 61, Issue 2, Pages 63-97Publisher
JAPAN NEUROSURGICAL SOC
DOI: 10.2176/nmc.st.2020-0292
Keywords
clinical guideline; idiopathic normal pressure hydrocephalus; diagnosis; treatment; management
Categories
Funding
- Ministry of Health, Labour and Welfare of Japan Sciences Research Grants Subsidy for Intractable Diseases Policy Research Project [2017-Nanchi-General-037]
Ask authors/readers for more resources
This article introduces the third edition of the management guidelines for idiopathic normal pressure hydrocephalus (iNPH), including a new disease classification and diagnostic algorithm, aimed at promoting international research and improving the diagnosis and treatment of iNPH.
Among the various disorders that manifest with gait disturbance, cognitive impairment, and urinary incontinence in the elderly population, idiopathic normal pressure hydrocephalus (iNPH) is becoming of great importance. The first edition of these guidelines for management of iNPH was published in 2004, and the second edition in 2012, to provide a series of timely, evidence-based recommendations related to iNPH. Since the last edition, clinical awareness of iNPH has risen dramatically, and clinical and basic research efforts on iNPH have increased significantly. This third edition of the guidelines was made to share these ideas with the international community and to promote international research on iNPH. The revision of the guidelines was undertaken by a multidisciplinary expert working group of the Japanese Society of Normal Pressure Hydrocephalus in conjunction with the Japanese Ministry of Health, Labour and Welfare research project. This revision proposes a new classification for NPH. The category of iNPH is clearly distinguished from NPH with congenital/developmental and acquired etiologies. Additionally, the essential role of disproportionately enlarged subarachnoid-space hydrocephalus (DESH) in the imaging diagnosis and decision for further management of iNPH is discussed in this edition. We created an algorithm for diagnosis and decision for shunt management. Diagnosis by biomarkers that distinguish prognosis has been also initiated. Therefore, diagnosis and treatment of iNPH have entered a new phase. We hope that this third edition of the guidelines will help patients, their families, and healthcare professionals involved in treating iNPH.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available